Norepinephrine Bitartrate Injection, Solution, Concentrate
Product Images NDC 70121-1576

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Norepinephrine Bitartrate (NDC 70121-1576). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Norepinephrine Bitartrate Injection Usp 1)

FDA Label Image

1 (Norepinephrine Bitartrate Injection Usp 2)

FDA Label Image

1 (Norepinephrine Bitartrate Injection Usp 3)

NDC 70121-1576-7 Sterile Injection Norepinephrine Bitartrate Injection, USP is a potent drug that should be controlled by frequent determination of blood pressure. It should not be left unattended during administration. The drug should be diluted before use, and any unused portion discarded. The drug is light-sensitive and contains sulfites. The single-dose vials should be stored between 20° to 25°C (68°F to 77°F). The usual dosage and dilution information can be found in the package insert. The product is manufactured by AnelPhamaceuis P L and distributed by AnelPhamacenias L. This drug is Rx only and has an Mg Lic. No. G28/1539.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.